Tarsus Pharmaceuticals, Inc. TARS Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Tarsus Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s interest coverage?
- Tarsus Pharmaceuticals, Inc. (TARS) reported interest coverage of -5.7× in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s interest coverage changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s interest coverage increased by 52.3% year-over-year, from -12× to -5.7×.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s interest coverage?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s interest coverage has grown at a -44.0% compound annual growth rate (CAGR), from -143.6× to -7.9×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.